Post-finasteride syndrome
Finasteride, a 5α-reductase inhibitor, was approved in 1992 for the treatment of benign prostatic hyperplasia; a lower dose (1 mg) was approved in 1997 for male pattern baldness. A second…
Read Original Article: Post-finasteride syndrome »
